Join Us for the Virtual Advantage+ Medicaid Policy Summit
Introducing the Advantage+ Medicaid Policy Summit, a one-day virtual event focused exclusively on the evolving Medicaid policy and drug pricing landscape.
This event is designed for manufacturers and Medicaid market access teams, state pharmacy directors and their staff, associations and advocacy groups, and policy leaders across the ecosystem.
Medicaid policy continues to evolve at an unprecedented pace, from the implementation of HR1 (The One Big Beautiful Bill Act), to states grappling with shifting budgets, and CMMI demonstrations like GENEROUS and BALANCE. More so, Medicaid does not operate in a silo, especially as new policies reference both international and domestic payers.
To develop a full understanding of Medicaid today, the Summit will also explore the impacts of 340B, Prescription Drug Affordability Boards, the Inflation Reduction Act and Maximum Fair Price, and PBM reform. To cap off the day, we will explore how Medicaid and Managed Care are using AI and automation to navigate these changes.
What makes this August timing so valuable is that the speculation will be over. State budgets will be signed; legislative sessions will be closed; and Congress is likely to be in recess. You'll receive the real picture of what's happening at both the state and federal level.
Registration includes full-day access to the live virtual event, on-demand recordings of all sessions, and pharmacy law continuing education by the Accreditation Council for Pharmacy Education.
Discounted registration is available for Artia Solutions and Petauri clients, Advantage+ subscribers, associations, and advocacy groups. Registration is free for state pharmacy directors and their teams, as well as pharmacy students.
Please note that registration sales are final. Contact us for discount codes or with any questions.
About the Author
Join Us for the Virtual Advantage+ Medicaid Policy Summit
A one-day virtual event focused exclusively on the evolving Medicaid policy and drug pricing landscape.
Demystifying Most Favored Nation Innovation Models
MFN pricing is here, expanding, and increasingly complex. CMS is advancing multiple Innovation Center models that tie U.S. drug prices to international benchmarks across Medicaid and Medicare with implications for rebates, strategy, and market access.
Medicaid Policy in 2025: Key Disruptions & Strategic Implications for 2026
This year brought major disruption to Medicaid and drug pricing policy, reshaping the environment for pharmaceutical manufacturers. This recap highlights the biggest changes and lays out what to expect in 2026.